DF-006
DF-006 is an innovative orally active agonist of ALPK1 (α-kinase 1) . It stimulates the innate immune response in the liver by activating the NF-κB pathway. DF-006 effectively reduces serum levels of hepatitis B virus (HBV) DNA (EC50 = 2.7 pM), HBsAg, and HBeAg, demonstrating potent antiviral activity, making it suitable for immunotherapy research in chronic hepatitis B (CHB) .
Product Specifications
CAS Number
2311947-41-6
Field of Research
Infectious Disease & Virology
Smiles
O[C@H]1[C@H] (N2C=3C (N=C2) =C (N) N=CN3) O[C@H] (COP (OP (O[C@H]4[C@@H] (OC (C) =O) [C@@H] (OC (C) =O) [C@H] (OC (C) =O) [C@@] ([C@H] (COC (C) =O) F) (O4) [H]) (=O) O) (=O) S) [C@H]1O
Molecular Formula
C25H34FN5O18P2S
Molecular Weight
805.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ICP12MIX3A 100 mL
ICP Multi Elem (12) Std 100ppm each in 2-5% HNO3 - 100ML
Sign In for Pricing
View Details 